Novel regulation of protein kinase C-η

Biochemical and Biophysical Research Communications

Volumn 425, Issue 4, 2012, Pages 836-841

  Pal, Deepanwita ^a   Outram, Shalini Persaud ^a,b   Basu, Alakananda ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Phosphorylation; PKC ; PKC ; Tumor promoter; Upregulation

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; INDOLACTAM V; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL DIBUTYRATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C IOTA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CARBAZOLES; CELL LINE, TUMOR; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INDOLES; MALEIMIDES; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; PROTEIN KINASE INHIBITORS; UP-REGULATION;

EID: 84866003880     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.163     Document Type: Article

References (44)

1. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258:607-614.
2. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 2007, 7:281-294.
3. Steinberg S.F. Structural basis of protein kinase C isoform function. Physiol. Rev. 2008, 88:1341-1378.
4. Blumberg P.M. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res. 1988, 48:1-8.
5. Basu A., Pal D. Two faces of protein kinase Cdelta: the contrasting roles of PKCdelta in cell survival and cell death. Sci. World J. 2010, 10:2272-2284.
6. Gould C.M., Newton A.C. The life and death of protein kinase C. Curr. Drug Targets 2008, 9:614-625.
7. Parekh D.B., Ziegler W., Parker P.J. Multiple pathways control protein kinase C phosphorylation. Embo J. 2000, 19:496-503.
8. Newton A.C. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 2003, 370:361-371.
9. Flint A.J., Paladini R.D., Koshland D.E. Autophosphorylation of protein kinase C at three separated regions of its primary sequence. Science 1990, 249:408-411.
10. Dutil E.M., Keranen L.M., DePaoli-Roach A.A., Newton A.C. In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J. Biol. Chem. 1994, 269:29359-29362.
11. Basu A., Sridharan S., Persaud S. Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2. Cell Signal. 2009, 21:1680-1685.
12. Rybin V.O., Sabri A., Short J., Braz J.C., Molkentin J.D., Steinberg S.F. Cross-regulation of novel protein kinase C (PKC) isoform function in cardiomyocytes. Role of PKC epsilon in activation loop phosphorylations and PKC delta in hydrophobic motif phosphorylations. J. Biol. Chem. 2003, 278:14555-14564.
13. Basu A. The potential of protein kinase C as a target for anticancer treatment. Pharmacol. Ther. 1993, 59:257-280.
14. Kashiwagi M., Ohba M., Chida K., Kuroki T. Protein kinase C eta (PKC eta): its involvement in keratinocyte differentiation. J. Biochem. 2002, 132:853-857.
15. Fima E., Shtutman M., Libros P., Missel A., Shahaf G., Kahana G., Livneh E. PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells. Oncogene 2001, 20:6794-6804.
16. Hussaini I.M., Karns L.R., Vinton G., Carpenter J.E., Redpath G.T., Sando J.J., VandenBerg S.R. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. J. Biol. Chem. 2000, 275:22348-22354.
17. Akkaraju G.R., Basu A. Overexpression of protein kinase C-eta attenuates caspase activation and tumor necrosis factor-alpha-induced cell death. Biochem. Biophys. Res. Commun. 2000, 279:103-107.
18. Hashimoto Y., Osada S., Ohno S., Kuroki T. A Ca(2+)-independent protein kinase C, nPKC eta: its structure, distribution and possible function. Tohoku J. Exp. Med. 1992, 168:275-278.
19. Masso-Welch P.A., Winston J.S., Edge S., Darcy K.M., Asch H., Vaughan M.M., Ip M.M. Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Res. Treat. 2001, 68:211-223.
20. Basu A. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha. Mol. Pharmacol. 1998, 53:105-111.
21. Hussaini I.M., Carpenter J.E., Redpath G.T., Sando J.J., Shaffrey M.E., Vandenberg S.R. Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neuro Oncol. 2002, 4:9-21.
22. Sonnemann J., Gekeler V., Ahlbrecht K., Brischwein K., Liu C., Bader P., Muller C., Niethammer D., Beck J.F. Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel. Cancer Lett. 2004, 209:177-185.
23. Raveh-Amit H., Hai N., Rotem-Dai N., Shahaf G., Gopas J., Livneh E. Protein kinase Ceta activates NF-kappaB in response to camptothecin-induced DNA damage. Biochem. Biophys. Res. Commun. 2011, 412:313-317.
24. Sonnemann J., Gekeler V., Sagrauske A., Muller C., Hofmann H.P., Beck J.F. Down-regulation of protein kinase Ceta potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells. Mol. Cancer Ther. 2004, 3:773-781.
25. Chen C.C., Wang J.K., Chen W.C. TPA induces translocation but not down-regulation of new PKC isoform eta in macrophages, MDCK cells and astrocytes. FEBS Lett. 1997, 412:30-34.
26. Resnick M.S., Luo X., Vinton E.G., Sando J.J. Selective up-regulation of protein kinase C eta in phorbol ester-sensitive versus -resistant EL4 mouse thymoma cells. Cancer Res. 1997, 57:2209-2215.
27. Lu D., Huang J., Basu A. Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death. J. Biol. Chem. 2006, 281:22799-22807.
28. Basu A., Kozikowski A.P., Lazo J.S. Structural requirements of lyngbyatoxin A for activation and downregulation of protein kinase C. Biochemistry 1992, 31:3824-3830.
29. Bacher N., Zisman Y., Berent E., Livneh E. Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol. Cell. Biol. 1991, 11:126-133.
30. Lachmann S., Bar S., Rommelaere J., Nuesch J.P. Parvovirus interference with intracellular signalling: mechanism of PKCeta activation in MVM-infected A9 fibroblasts. Cell Microbiol. 2008, 10:755-769.
31. Ziegler W.H., Parekh D.B., Le Good J.A., Whelan R.D., Kelly J.J., Frech M., Hemmings B.A., Parker P.J. Rapamycin-sensitive phosphorylation of PKC on a carboxy-terminal site by an atypical PKC complex. Curr. Biol. 1999, 9:522-529.
32. Hansra G., Garcia-Paramio P., Prevostel C., Whelan R.D., Bornancin F., Parker P.J. Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes. Biochem. J. 1999, 342(Pt 2):337-344.
33. Lee H.W., Smith L., Pettit G.R., Smith J.B. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts. Mol. Pharmacol. 1997, 51:439-447.
34. Prevostel C., Alice V., Joubert D., Parker P.J. Protein kinase C(alpha) actively downregulates through caveolae-dependent traffic to an endosomal compartment. J. Cell Sci. 2000, 113(Pt 14):2575-2584.
35. Leontieva O.V., Black J.D. Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cells. J. Biol. Chem. 2004, 279:5788-5801.
36. Cameron A.J., Escribano C., Saurin A.T., Kostelecky B., Parker P.J. PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity. Nat. Struct. Mol. Biol. 2009, 16:624-630.
37. Kang B.S., French O.G., Sando J.J., Hahn C.S. Activation-dependent degradation of protein kinase C eta. Oncogene 2000, 19:4263-4272.
38. Balendran A., Hare G.R., Kieloch A., Williams M.R., Alessi D.R. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett. 2000, 484:217-223.
39. Chida K., Hara T., Hirai T., Konishi C., Nakamura K., Nakao K., Aiba A., Katsuki M., Kuroki T. Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res. 2003, 63:2404-2408.
40. Abu-Ghanem S., Oberkovitz G., Benharroch D., Gopas J., Livneh E. PKCeta expression contributes to the resistance of Hodgkin's lymphoma cell lines to apoptosis. Cancer Biol. Ther. 2007, 6:1375-1380.
41. Krasnitsky E., Baumfeld Y., Freedman J., Sion-Vardy N., Ariad S., Novack V., Livneh E. PKCeta is a novel prognostic marker in non-small cell lung cancer. Anticancer Res. 2012, 32:1507-1513.
42. Lu H.C., Chou F.P., Yeh K.T., Chang Y.S., Hsu N.C., Chang J.G. Analysing the expression of protein kinase C eta in human hepatocellular carcinoma. Pathology 2009, 41:626-629.
43. Basu A., Sivaprasad U. Protein kinase Cepsilon makes the life and death decision. Cell Signal. 2007, 19:1633-1642.
44. Karp G., Maissel A., Livneh E. Hormonal regulation of PKC: estrogen up-regulates PKCeta expression in estrogen-responsive breast cancer cells. Cancer Lett. 2007, 246:173-181.